Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): IN/PCT/2001/799/MUM
Who filed: Cipla Ltd.
Country: India
Opposition type: Post-Grant
Opposition status: Compulsory License was issued, opposition decision not available
Date: 30-03-2009
Patent type: Molecules

Click within the document, or manually enter the page number below

Cipla Ltd. opposition, valganciclovir (VAL) , (959/MAS/1995 (granted as 207232))

Countries: India Date: 2009
Cipla Ltd. opposition, tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) , (3383/DELNP/2005)

Countries: India Date: 2009
Cipla Ltd. opposition, darunavir (DRV) , (1647/DELNP/2004)

Countries: India Date: 2009
Cipla Ltd. opposition, sunitinib (su) , (IN/PCT/2002/00785/DEL )

Countries: India Date: 2012
Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (676/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Countries: India Date: 2009
Matrix Laboratories Ltd. opposition, ritonavir (r, RTV) , (1638/MUMNP/2007 (Divisional of PCT/2001/00018/MUM))

Countries: India Date: 2009
Matrix Laboratories Ltd. opposition, atazanavir (ATV) , (WO/2013/176772)

Countries: India Date: 2009
Natco Pharma Ltd. opposition, Paclitaxel, (2899/DELNP/2005)

Countries: India Date: 2014
Cipla Ltd. opposition, lopinavir/ritonavir (LPV/r) , (726/MUMNP/2009 (Divisional of 339/MUMNP/2006))

Countries: India Date: 2010
Cipla Ltd. opposition, ritonavir (r, RTV) , (PCT/2001/00018/MUM)

Countries: India Date: 2008

Cipla Ltd. Opposition, Sorafenib, (In/Pct/2001/799/Mum)